ArticleiGIE : innovation, investigation and insights2024
Retrograde balloon pull-through technique for benign esophageal strictures: a single-center pilot experience.
Article in iGIE : innovation, investigation and insights, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Antegrade savary dilation and static balloon dilation are the mainstays of management of simple and complex benign esophageal strictures (BESs). A modified technique, termed retrograde balloon dilation, has potential advantages for the management of BESs. Efficacy and safety data on this technique are limited. We report a single-center experience of retrograde balloon dilation for BESs. Methods: We conducted a retrospective study evaluating retrograde balloon and antegrade savary dilation for BESs in 53 unique patients who met inclusion criteria, including 23 undergoing a retrograde balloon pull-through technique and 30 undergoing antegrade savary dilation. The primary endpoint was technical success, defined as achieving a luminal diameter of ≥16 mm. Secondary endpoints were repeat dilation rates within 1 year after achieving therapeutic endpoint dilation and adverse events. Results: Technical success was achieved in 22 of 23 patients (95.7%) with the retrograde balloon pull-through technique and in all 30 patients (100%) with antegrade savary dilation ( Conclusions: Our experience suggests that retrograde balloon pull-through dilation is effective and safe for simple and complex benign esophageal stenosis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.